Among patients with
hypertension at high risk of cardiovascular disease, a program that consisted of patients measuring their blood pressure and adjusting their antihypertensive medication accordingly resulted in lower systolic blood pressure at 12 months compared to patients who received usual care, according to a study in the August 27 issue of JAMA.
Not exact matches
Furthermore, a child who is obese by age 12 has more than a 75 percent chance
of becoming an obese adult,
at risk for Type 2 diabetes,
cardiovascular disease, stroke,
hypertension,
high blood pressure, gallbladder
disease, asthma and certain cancers.
A potential explanation for the secular trend may be that while improved treatment for
cardiovascular risk factors or complicating
diseases has reduced mortality in all weight classes, the effects may have been greater
at higher BMI levels than
at lower BMI levels.12 Because obesity is a causal
risk factor for
hypertension, diabetes,
cardiovascular disease, and dyslipidemia,15,19 - 22 obese individuals may have had a
higher selective decrease in mortality.18 Indirect evidence
of this effect is seen in the findings as the deaths occur
at similar time periods in the 3 cohorts, but cohorts recruited
at later periods have an increase in the BMI associated with the lowest mortality, possibly suggesting a period effect related to changes in clinical practice, such as improved treatments, or general public health status, such as decreased smoking or increased physical activity.
Zachary T. Bloomgarden, MD, an endocrinologist
at Mount Sinai School
of Medicine in New York City who specializes in diabetes, prescribes these drugs to most
of his patients, particularly those with
hypertension,
cardiovascular disease, or
risk factors for heart
disease, such as
high cholesterol.
And all
of these benefits combine to help lower a person's
risk of cardiovascular disease (among many other
diseases including
at least 11 known cancers) by reducing
risk factors like obesity,
hypertension, and
high blood cholesterol.
CDC speculates that the observed association between low sodium intake and increased CVD
risk may have been due to a
higher proportion
of participants in the low sodium group, compared to groups with
higher intake levels, who had diabetes,
hypertension, and pre-existing
cardiovascular disease at baseline and therefore may have consumed less sodium, leading to a noncausal association between sodium intake and increased
cardiovascular events.
The Third National Health and Nutrition Examination Survey (NHANES III) looked
at the effect
of high sodium intake on the
risks of cardiovascular disease mortality; including
hypertension risk.
Queensland Aboriginal and Islander Health Council (QAIHC) data show good performance in
risk factor monitoring and the management
of hypertension and chronic
disease.15 Box 2 shows improving performance in completion
of health assessments — a first step in prevention activity — over the past 4 years.22 The Torpedo study, a randomised controlled trial
of the use
of an electronic decision - support system measuring absolute
cardiovascular risk, shows ACCHSs outperforming general practices in managing
risk.21 Data collected in late 2011 show that the ACCHSs sites had significantly more patients
at high risk being prescribed best - practice medications than the general practice sites
at baseline, and this gap was sustained through the intervention period (Box 3).23